Published in Lancet on June 18, 1994
Varicella-zoster virus. Clin Microbiol Rev (1996) 3.03
Preventing varicella-zoster disease. Clin Microbiol Rev (2005) 1.55
Genitourinary anomaly in congenital varicella syndrome: case report and review. Pediatr Nephrol (2004) 1.38
Viral infections during pregnancy. Am J Reprod Immunol (2015) 1.17
Herpes simplex and varicella-zoster virus infections during pregnancy: current concepts of prevention, diagnosis and therapy. Part 2: Varicella-zoster virus infections. Med Microbiol Immunol (2006) 1.15
Varicella during pregnancy. Maternal and fetal effects. West J Med (1995) 1.09
Nosocomial spread of viral disease. Clin Microbiol Rev (2001) 1.05
The burden of varicella in Germany. Potential risks and economic impact. Eur J Health Econ (2004) 1.00
Varicella-zoster virus (chickenpox) infection in pregnancy. BJOG (2011) 0.99
Seroprevalence of varicella antibodies among pregnant women in Lyon-France. Eur J Epidemiol (2007) 0.99
Human trophoblasts confer resistance to viruses implicated in perinatal infection. Am J Obstet Gynecol (2014) 0.96
Varicella vaccination in Europe: are we ready for a universal childhood programme? Eur J Pediatr (2007) 0.96
Congenital varicella syndrome: the evidence for secondary prevention with varicella-zoster immune globulin. CMAJ (2011) 0.94
The seroepidemiology of varicella zoster virus among pregnant Bangladeshi and white British women in the London Borough of Tower Hamlets, UK. Epidemiol Infect (2007) 0.93
Best practice in primary care pathology: review 6. J Clin Pathol (2006) 0.93
Vaccinations for pregnant women. Obstet Gynecol (2015) 0.90
Increased seroprevalence of IgG-class antibodies against cytomegalovirus, parvovirus B19, and varicella-zoster virus in women working in child day care. BMC Public Health (2012) 0.88
Model structure analysis to estimate basic immunological processes and maternal risk for parvovirus B19. Biostatistics (2010) 0.88
Severe hydrocephalus associated with congenital varicella syndrome. CMAJ (2003) 0.87
Successes and challenges in varicella vaccine. Ther Adv Vaccines (2014) 0.86
The incidence of chickenpox in the community. Lessons for disease surveillance in sentinel practice networks. Eur J Epidemiol (2001) 0.86
The role of ultrasound in the diagnosis of fetal genetic syndromes. Best Pract Res Clin Obstet Gynaecol (2014) 0.85
Validity of self-reported varicella disease history in pregnant women attending prenatal clinics. Public Health Rep (2007) 0.83
Varicella susceptibility and transmission dynamics in Slovenia. BMC Public Health (2010) 0.81
A protein microarray immunoassay for the serological evaluation of the antibody response in vertically transmitted infections. Eur J Clin Microbiol Infect Dis (2009) 0.81
Chickenpox during pregnancy. Small but real risk. Can Fam Physician (1995) 0.79
The Antigenic Structure of Zika Virus and Its Relation to Other Flaviviruses: Implications for Infection and Immunoprophylaxis. Microbiol Mol Biol Rev (2017) 0.78
Perinatal cytomegalovirus and varicella zoster virus infections: epidemiology, prevention, and treatment. Clin Perinatol (2014) 0.78
Incidence of vesicobullous and erosive disorders of neonates. J Dermatol Case Rep (2011) 0.78
Prenatal screening: invasive diagnostic approaches. Childs Nerv Syst (2003) 0.78
Incidence and effects of Varicella Zoster Virus infection on academic activities of medical undergraduates--a five-year follow-up study from Sri Lanka. BMC Infect Dis (2010) 0.77
The varicella-zoster virus portal protein is essential for cleavage and packaging of viral DNA. J Virol (2014) 0.76
The unique immunological and microbial aspects of pregnancy. Nat Rev Immunol (2017) 0.75
Case 1: Vesicular rash in an infant. Paediatr Child Health (2010) 0.75
Follow-up of pregnant women exposed to chicken pox: an audit of relationship between level of antibody and development of chicken pox. Eur J Clin Microbiol Infect Dis (2011) 0.75
A Prospective Study of Herpes Zoster in Children. Indian J Dermatol (2016) 0.75
Preventing congenital varicella syndrome with immunization. CMAJ (2011) 0.75
Varicella in pregnancy. Lancet (1994) 0.75
Microbiology laboratory and the management of mother-child varicella-zoster virus infection. World J Virol (2016) 0.75
Risk of varicella infection during late pregnancy. Can Fam Physician (2003) 0.75
Primary varicella in an immunocompetent adult. J Clin Aesthet Dermatol (2009) 0.75
Serological Evaluation of Immunity to the Varicella-Zoster Virus Based on a Novel Competitive Enzyme-Linked Immunosorbent Assay. Sci Rep (2016) 0.75
Predictive value of a self-reported history of varicella infection in determining immunity in adults. CMAJ (2004) 0.75
Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association. Lancet (1999) 11.10
The new measles campaign. BMJ (1994) 6.59
Willingness to pay for a quality-adjusted life year: in search of a standard. Med Decis Making (2000) 4.86
Relation of particle dimension to carcinogenicity in amphibole asbestoses and other fibrous minerals. J Natl Cancer Inst (1981) 4.60
Consequences of confirmed maternal rubella at successive stages of pregnancy. Lancet (1982) 4.56
Carcinogenicity of fibrous glass: pleural response in the rat in relation to fiber dimension. J Natl Cancer Inst (1977) 4.28
Impact of anti-vaccine movements on pertussis control: the untold story. Lancet (1998) 4.18
Salivary diagnosis of measles: a study of notified cases in the United Kingdom, 1991-3. BMJ (1994) 4.10
A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines. Lancet (1995) 3.93
Cell migration inhibition factor released by antigen from human peripheral lymphocytes. Nature (1968) 3.62
Oral zinc in macular degeneration. Arch Ophthalmol (1988) 3.58
Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J Neurosci (2001) 3.46
Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England. Lancet (2001) 3.19
SEX DIFFERENCES IN KIDNEY MORPHOLOGY AND CHLOROFORM NECROSIS. Science (1945) 3.18
Surveillance of antibody to measles, mumps, and rubella by age. BMJ (1988) 3.11
Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma. J Clin Invest (1996) 3.10
Treatment of Early Mammary Carcinoma: A Cooperative International Study. Ann Surg (1963) 3.07
Elevated maternal hemoglobin A1c in early pregnancy and major congenital anomalies in infants of diabetic mothers. N Engl J Med (1981) 2.89
Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection. Infect Immun (2001) 2.86
Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. J Clin Invest (1999) 2.81
Congenital rubella in babies of south Asian women in England and Wales: an excess and its causes. Br Med J (Clin Res Ed) (1987) 2.81
Case series analysis of adverse reactions to vaccines: a comparative evaluation. Am J Epidemiol (1996) 2.65
Carcinoembryonic antigen (CEA) assay. A laboratory adjunct in the diagnosis and management of cancer. Hum Pathol (1974) 2.57
Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers. J Infect Dis (2000) 2.57
Rubella vaccination in the UK: time for a complete strategy. Lancet (1985) 2.54
Supportive-expressive group therapy and distress in patients with metastatic breast cancer: a randomized clinical intervention trial. Arch Gen Psychiatry (2001) 2.51
Varicella-zoster virus epidemiology--a changing scene? J Infect Dis (1996) 2.48
Effect of selective vaccination on rubella susceptibility and infection in pregnancy. Br Med J (Clin Res Ed) (1985) 2.48
Fetal infection after maternal reinfection with rubella: criteria for defining reinfection. BMJ (1989) 2.48
Symptoms after primary immunisation with DTP and with DT vaccine. Lancet (1984) 2.48
Shift in age in chickenpox. Lancet (1993) 2.46
Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis. Proc Natl Acad Sci U S A (1995) 2.44
Cell position and light influence C4 versus C3 patterns of photosynthetic gene expression in maize. EMBO J (1988) 2.37
Meningococcal C polysaccharide vaccine induces immunologic hyporesponsiveness in adults that is overcome by meningococcal C conjugate vaccine. J Infect Dis (2000) 2.35
Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009. Health Technol Assess (2010) 2.33
The epidemiology of measles in England and Wales: rationale for the 1994 national vaccination campaign. Commun Dis Rep CDR Rev (1994) 2.32
A longitudinal household study of Streptococcus pneumoniae nasopharyngeal carriage in a UK setting. Epidemiol Infect (2005) 2.32
Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization. J Infect Dis (1998) 2.26
Bordetella pertussis surveillance in England and Wales: 1995-7. Epidemiol Infect (1999) 2.24
Meningococcal serogroup C conjugate vaccine is immunogenic in infancy and primes for memory. J Infect Dis (1999) 2.16
Varicella in maternity units. Lancet (1990) 2.16
Rubella susceptibility and the continuing risk of infection in pregnancy. Br Med J (Clin Res Ed) (1987) 2.13
The induction of immunologic memory after vaccination with Haemophilus influenzae type b conjugate and acellular pertussis-containing diphtheria, tetanus, and pertussis vaccine combination. J Infect Dis (1999) 2.04
Combined serum paraoxonase knockout/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis. J Biol Chem (2000) 2.02
Fat embolism prophylaxis with corticosteroids. A prospective study in high-risk patients. Ann Intern Med (1983) 1.99
Interpretation of serological surveillance data for measles using mathematical models: implications for vaccine strategy. Epidemiol Infect (1995) 1.89
Pre-eclampsia and serum antibodies to oxidised low-density lipoprotein. Lancet (1994) 1.88
Increased autoantibody titers against epitopes of oxidized LDL in LDL receptor-deficient mice with increased atherosclerosis. Arterioscler Thromb Vasc Biol (1995) 1.88
Vasopressin in prevention of lumbar puncture headache. Br Med J (1968) 1.85
Pneumococcal bacteraemia and meningitis in England and Wales, 1993 to 1995. Commun Dis Public Health (1998) 1.80
The Support of Research in Medical and Allied Fields for the Period 1946 through 1951. Science (1952) 1.80
Macrophage-derived foam cells freshly isolated from rabbit atherosclerotic lesions degrade modified lipoproteins, promote oxidation of low-density lipoproteins, and contain oxidation-specific lipid-protein adducts. J Clin Invest (1991) 1.79
Impact of meningococcal C conjugate vaccine in the UK. J Med Microbiol (2002) 1.77
Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children. Immunology (1998) 1.75
Increased blood pressure during potassium depletion in normotensive men. N Engl J Med (1989) 1.69
Influence of age on pain relief from analgesics. A study of postoperative patients. JAMA (1971) 1.68
Severity of whooping cough in England before and after the decline in pertussis immunisation. Arch Dis Child (1984) 1.67
Neisseria meningitidis group B correlates of protection and assay standardization--international meeting report Emory University, Atlanta, Georgia, United States, 16-17 March 2005. Vaccine (2006) 1.67
The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region. Vaccine (2007) 1.66
Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein. J Clin Invest (1996) 1.65
Thyroid carcinoma in single cold nodules and in cold nodules of multinodular goiters. Endocr Pract (2001) 1.64
Genotypic variation in the Bordetella pertussis virulence factors pertactin and pertussis toxin in historical and recent clinical isolates in the United Kingdom. Infect Immun (2001) 1.64
Surveillance of symptoms following MMR vaccine in children. Practitioner (1989) 1.63
Severe and unrecognised: pertussis in UK infants. Arch Dis Child (2003) 1.62
The seroepidemiology of Bordetella pertussis infection in Western Europe. Epidemiol Infect (2005) 1.60
From the fetal liver to spleen and gut: the highway to natural antibody. Mucosal Immunol (2009) 1.59
Enhanced macrophage uptake of low density lipoprotein after self-aggregation. Arteriosclerosis (1988) 1.57
Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes. Arterioscler Thromb Vasc Biol (1998) 1.57
Ten years of serological surveillance in England and Wales: methods, results, implications and action. Int J Epidemiol (2000) 1.55
The Drosophila Polycomb group gene Sex comb on midleg (Scm) encodes a zinc finger protein with similarity to polyhomeotic protein. Development (1996) 1.54
Pyrexia after diphtheria/tetanus/pertussis and diphtheria/tetanus vaccines. Arch Dis Child (1983) 1.52
The epitopes for some antiphospholipid antibodies are adducts of oxidized phospholipid and beta2 glycoprotein 1 (and other proteins). Proc Natl Acad Sci U S A (1997) 1.51
Simple and choice reaction time following severe head injury. Cortex (1970) 1.51
Predicting bacteremia in patients with sepsis syndrome. Academic Medical Center Consortium Sepsis Project Working Group. J Infect Dis (1997) 1.50
Rational programme for screening travellers for antibodies to hepatitis A virus. Lancet (1988) 1.50
Predicting the impact of measles vaccination in England and Wales: model validation and analysis of policy options. Epidemiol Infect (1995) 1.50
Operative transluminal balloon angioplasty. Adjunct to coronary bypass for extended myocardial revascularization of more than 3000 lesions in 1000 patients. J Thorac Cardiovasc Surg (1990) 1.49
Endoplasmic reticulum stress proteins block oxidant-induced Ca2+ increases and cell death. J Biol Chem (1998) 1.49
The sero-epidemiology of diphtheria in Western Europe. ESEN Project. European Sero-Epidemiology Network. Epidemiol Infect (2000) 1.48
Estimating influenza vaccine effectiveness using routinely collected laboratory data. J Epidemiol Community Health (2009) 1.48
A serine proteinase inhibitor locus at 18q21.3 contains a tandem duplication of the human squamous cell carcinoma antigen gene. Proc Natl Acad Sci U S A (1995) 1.47
Congenital rubella in the Asian community in Britain. BMJ (1990) 1.46
Exanthem subitum (roseola infantum) misdiagnosed as measles or rubella [corrected]. BMJ (1996) 1.46
Cancelled elective operations: an observational study from a district general hospital. J Health Organ Manag (2007) 1.45
Secondary analyses of the efficacy of two acellular pertussis vaccines evaluated in a Swedish phase III trial. Vaccine (1990) 1.43
Age-specific antibody prevalence to hepatitis A in England: implications for disease control. Epidemiol Infect (1994) 1.43
Varicella vaccination: a double-edged sword? Commun Dis Public Health (2002) 1.43
Measles, mumps, and rubella vaccination. BMJ (1992) 1.43
Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST) Circulation (1994) 1.43
Invasive pneumococcal disease in England and Wales: vaccination implications. J Infect Dis (2000) 1.42
Expression and properties of wild-type and mutant forms of the Drosophila sex comb on midleg (SCM) repressor protein. Genetics (1998) 1.41
Mumps surveillance in England and Wales supports introduction of two dose vaccination schedule. Commun Dis Rep CDR Rev (1997) 1.40
Whooping-cough notifications. Lancet (1980) 1.36
MMR and autism: further evidence against a causal association. Vaccine (2001) 1.34
Interpreting serological surveys using mixture models: the seroepidemiology of measles, mumps and rubella in England and Wales at the beginning of the 21st century. Epidemiol Infect (2006) 1.34
HIV-1 infection: no evidence of cognitive decline during the asymptomatic stages. The Multicenter AIDS Cohort Study. Neurology (1990) 1.34
Low density lipoprotein rich in oleic acid is protected against oxidative modification: implications for dietary prevention of atherosclerosis. Proc Natl Acad Sci U S A (1990) 1.34
Gender differences in the functional organization of the brain for working memory. Neuroreport (2000) 1.33
The current burden of pneumococcal disease in England and Wales. J Infect (2006) 1.32